Overactive Bladder Syndrome Clinical Trials

13 recruitingLast updated: May 9, 2026

There are 13 actively recruiting overactive bladder syndrome clinical trials across 6 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Al Minyā, Egypt, Alexandria, Egypt, Aswān, Egypt. Updated daily from ClinicalTrials.gov.


Overactive Bladder Syndrome Trials at a Glance

13 actively recruiting trials for overactive bladder syndrome are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Al Minyā, Alexandria, and Aswān. Lead sponsors running overactive bladder syndrome studies include Corewell Health East, Duke University, and Benha University.

Browse overactive bladder syndrome trials by phase

Treatments under study

About Overactive Bladder Syndrome Clinical Trials

Looking for clinical trials for Overactive Bladder Syndrome? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Overactive Bladder Syndrome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Overactive Bladder Syndrome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 2Phase 3

Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

Urinary IncontinenceOveractive BladderUrologic Diseases+1 more
Northwestern University66 enrolled1 locationNCT05878951
Recruiting
Not Applicable

Impact of TTNS on Bladder Symptoms Among People With MS, A RCT

Overactive Bladder Syndrome
Hawra Al-Dandan72 enrolled1 locationNCT06341673
Recruiting

Effects of Microbiological and Immunological Factors on the Lower Urinary Tract

Non Muscle Invasive Bladder CancerChronic pelvic painAsymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder Emptying+5 more
University of Zurich800 enrolled1 locationNCT07494864
Recruiting
Phase 4

Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study

Overactive Bladder (OAB)Overactive Bladder Syndrome
Mansoura University480 enrolled14 locationsNCT07416968
Recruiting
Not Applicable

Yoga for Treatment of Overactive Bladder in Pediatric Patients

Overactive BladderOveractive Bladder SyndromeOveractive Detrusor
Duke University40 enrolled1 locationNCT05895045
Recruiting
Phase 3

Oxybutynin for Post-surgical Bladder Pain and Urgency

Overactive Bladder SyndromeNeuropathic Bladder
University of California, Davis100 enrolled1 locationNCT03952299
Recruiting
Not Applicable

BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder

Urinary urgency.Overactive BladderUrinary Frequency+1 more
Corewell Health East166 enrolled1 locationNCT04873037
Recruiting
Not Applicable

Improving Overactive Bladder Treatment Access and Adherence

Urinary IncontinenceOveractive Bladder Syndrome
Stanford University30 enrolled1 locationNCT06094543
Recruiting
Not Applicable

Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial

Overactive Bladder Syndrome
Medical University of Vienna100 enrolled1 locationNCT06546189
Recruiting
Not Applicable

Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial

Urinary Urge IncontinenceOveractive Bladder Syndromedetrusor overactivity
Benha University48 enrolled1 locationNCT07184307
Recruiting
Not Applicable

Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation

Overactive Bladder (OAB)Overactive Bladder SyndromeTranscutaneous Posterior Tibial Nerve Stimulation (TTNS)
Ege University50 enrolled1 locationNCT07081412
Recruiting
Phase 2

Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome

Lower Urinary Tract SymptomsOveractive Bladder Syndrome
Iman Al-Naggar, PhD50 enrolled1 locationNCT06351683
Recruiting
Phase 4

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

Overactive Bladder Syndrome
Walter Reed National Military Medical Center152 enrolled1 locationNCT05221021